Empagliflozin restores cardiac function in obese-diabetic HFpEF mice but further alters gene expression - Quiz - MDSpire

Empagliflozin restores cardiac function in obese-diabetic HFpEF mice but further alters gene expression

  • By

  • Juliana Mira Hernandez

  • Logan R. J. Bailey

  • Victoria R. Salemme

  • Christopher Y. Ko

  • Erin Y. Shen

  • Megan Ngim

  • Duong T. Hoang

  • Melissa Corea

  • Julie Bossuyt

  • Jennifer M. Davis

  • Donald M. Bers

  • Bence Hegyi

  • May 21, 2026

  • 0 min

Share

Original Source(s)

Empagliflozin restores cardiac function in obese-diabetic HFpEF mice but further alters gene expression

  • by Juliana Mira Hernandez, Logan R. J. Bailey, Victoria R. Salemme, Christopher Y. Ko, Erin Y. Shen, Megan Ngim, Duong T. Hoang, Melissa Corea, Julie Bossuyt, Jennifer M. Davis, Donald M. Bers, Bence Hegyi

  • May 21, 2026

Related Content

Multimodality cardiovascular imaging in arrhythmic mitral valve prolapse: a state-of-the-art review from structural assessment to myocardial tissue characterization

Same-same, but different? Postoperative rhythm disturbances and other analysis after rotational Z-flap vs. patch repair of sinus venosus atrial defects

Cardiovascular sequelae of Long COVID: immune dysregulation inflammation as central drivers